芬兰2015年盆腔器官脱垂手术调查中的主要并发症分析
该研究为2015年芬兰盆腔器官脱垂手术的前瞻性队列,纳入3515例女性,比较自体组织修复、经阴道网片和腹部网片手术的并发症。1年内11.2%发生至少一种并发症,主要并发症(Clavien-Dindo III-V级)总体为3.3%,腹部网片最高(8.8%)。网片手术、手术时间长、既往POP手术和困难手术与主要并发症风险增加相关。
要点
- 1年内11.2%患者发生至少一种并发症,多数在术后2个月内。
- 主要并发症(Clavien-Dindo III-V级)总体3.3%,腹部网片8.8%最高。
- 网片手术、手术时间长、既往POP手术和困难手术增加主要并发症风险。
核心结论
- 无论术式如何,严重不良事件均罕见,但网片增强手术与主要并发症风险较高相关。
研究设计与样本
- 芬兰2015年盆腔器官脱垂手术调查为前瞻性队列,纳入2015年在芬兰进行的3515例POP手术。
- 随访1年,比较自体组织修复、经阴道网片和腹部网片手术的围术期、术后及晚期并发症。
- 主要并发症采用Clavien-Dindo分级评估,预测因素采用逻辑回归分析。
主要发现
- 1年内396例(11.2%)发生至少一种并发症:自体组织修复10.9%,经阴道网片11.7%,腹部网片13.5%。
- 术后感染(4.3%)和出血或血肿(2.6%)最常见,器官损伤发生率低。
- 网片增强手术的膀胱和肠道损伤率显著高于自体组织修复。
- 腹部网片修复的并发症相关再手术率显著高于自体组织修复(5.2% vs 1.8%,P=.001)。
- 经阴道网片修复的网片相关并发症诊断更常见。
关键数值与推荐
- 主要并发症(Clavien-Dindo III-V级)总体发生率为3.3%。
- 腹部网片手术主要不良事件率最高(8.8%),自体组织修复2.6%,经阴道网片4.9%。
- Clavien-Dindo IV或V级并发症罕见(低于0.6%)。
- 主要并发症风险增加的相关因素:经阴道网片aOR 2.23(95%CI 1.31-3.80),腹部网片aOR 3.02(95%CI 1.67-5.46)。
- 手术时间较长aOR 2.84(95%CI 1.78-4.53),既往POP手术aOR 1.68(95%CI 1.00-2.81),困难手术aOR 2.75(95%CI 1.63-4.62)。
临床怎么用
- 术前应告知患者网片增强手术尤其腹部网片的主要并发症风险较高。
- 对既往POP手术、预计手术困难或手术时间较长者,应加强围术期风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the major complications of pelvic organ prolapse (POP) surgery in Finland. METHODS: The Finnish Pelvic Organ Prolapse Surgery Survey 2015 study is a prospective cohort of POP surgeries performed in Finland in 2015. Perioperative, postoperative, and late complications during 1 year of follow-up were compared among native tissue repair, transvaginal mesh, and abdominal mesh surgery. Major complications were assessed using the Clavien-Dindo grading system. Predictive factors for major complications were studied with logistic regression analysis. RESULTS: Within 1 year after POP surgery, 396 (11.2%) of 3,515 women had at least one complication: 10.9% after native tissue, 11.7% after transvaginal mesh, and 13.5% after abdominal mesh repair. The majority of complications occurred within 2 months after surgery and postoperative infection (4.3%) and bleeding or hematoma (2.6%) were the most frequent. The incidence of organ injuries was low. Mesh-augmented surgery was associated with significantly higher rates of bladder and bowel injuries than native tissue surgery. Complication-related reoperations occurred significantly more often after abdominal mesh repair than native tissue surgery (5.2% vs 1.8%, P=.001). Mesh-related complications were diagnosed more often after transvaginal mesh repair. The overall rate of major complications (Clavien-Dindo grades III-V) was 3.3%. Abdominal mesh surgery was associated with the highest rate of major adverse events (8.8% vs native tissue repair 2.6% and transvaginal mesh 4.9%). The incidence of Clavien-Dindo grade IV or V complications was rare (less than 0.6%). Mesh surgery (transvaginal mesh adjusted odds ratio [aOR] 2.23, 95% CI 1.31-3.80, and abdominal mesh aOR 3.02, 95% CI 1.67-5.46), longer operating time (aOR 2.84, 95% CI 1.78-4.53), prior POP surgery (aOR 1.68, 95% CI 1.00-2.81) and difficult surgery (aOR 2.75, 95% CI 1.63-4.62) were associated with an increased risk for occurrence of major complications. CONCLUSION: Serious adverse events were rare regardless of the operative approach. However, mesh-augmented surgery was associated with higher risk for major complications.
引用
- Wihersaari O, Karjalainen P, Tolppanen AM, et al. Complications of Pelvic Organ Prolapse Surgery in the 2015 Finnish Pelvic Organ Prolapse Surgery Survey Study. Obstet Gynecol. 2020. PMID: 33156186. doi:10.1097/AOG.0000000000004159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。